| 6/20/2017 | BKDD | 21st Century Oncology granted final approval of $75 million DIP loan
|
| 6/2/2017 | BKCVDDEMHY | Prospect News reports zero new defaults for week of May 25 to May 31
|
| 5/25/2017 | BKDDHY | 21st Century Oncology files bankruptcy, inks restructuring agreement
|
| 3/9/2017 | BKDDHY | 21st Century Oncology forbearance periods, unit’s loan extended again
|
| 2/2/2017 | BKDDHY | 21st Century Oncology forbearance agreements, unit’s loan extended
|
| 12/16/2016 | BKDDHY | 21st Century Oncology transaction agreement deadline pushed to Jan. 4
|
| 12/7/2016 | BKDDHY | 21st Century Oncology defaults on 11% notes, setting off loan default
|
| 11/4/2016 | BKCVDDEMHY | Prospect News reports five new defaults for Oct. 27-Nov. 2, S&P three
|
| 11/2/2016 | BKDDHY | S&P downgrades 21st Century
|
| 11/1/2016 | BKDDHY | 21st Century Oncology misses coupon on 11% senior notes, seeks talks
|
| 8/23/2016 | BKDDHY | 21st Century Oncology’s 10-K report contains going-concern warning
|
| 8/16/2016 | BKDDHY | 21st Century Oncology credit agreement and 11% notes defaults waived
|
| 6/13/2016 | BKDD | 21st Century Oncology secures credit agreement amendment and waiver
|
| 5/17/2016 | BKDDHY | 21st Century Oncology gets default notice from trustee for 11% notes
|
| 5/17/2016 | BKDDHY | S&P cuts 21st Century Oncology, debt
|
| 5/16/2016 | BKDDHY | 21st Century fails to file 10-K, could set off default on loan, notes
|
| 3/29/2016 | BKDDHY | S&P might cut 21st Century Oncology
|
| 4/15/2015 | BKDDHY | S&P rates 21st Century loan B-, notes CCC
|
| 4/13/2015 | BK | Market Commentary: Top Right, Mitel Networks break; Air Medical, Concordia Healthcare, Tekni-Plex revise deals
|
| 3/19/2015 | BKBWHY | 21st Century Oncology cuts debt, ends year with $941 million debt
|
| 9/30/2014 | BKDD | S&P upgrades 21st Century, loans
|
| 9/26/2014 | BKCVDDEMIGPV | Market Commentary: High yield ends week in negative territory; GM Financial gains on S&P upgrade
|
| 9/26/2014 | BKDDHY | 21st Century Oncology gets $325 million investment, swaps restructuring
|
| 7/30/2014 | BKCVDDEMIGPV | Market Commentary: Mallinckrodt, upsized Paper Works price; Level 3 stays busy; First Data off after numbers
|
| 7/29/2014 | BKCVDDEMIGPV | Market Commentary: Upsized Level 3, other drive-bys pace $2.5 billion session; Windstream busy on REIT plan
|
| 7/21/2014 | BKCVDDEMIGPV | Market Commentary: Primary stays quiet amid more fund outflows, awaits Transworld; Radiation Therapy still active
|
| 7/14/2014 | BK | S&P: 21st Century Oncology view negative
|
| 7/9/2014 | BKCVDDEMIGPV | Market Commentary: Drive-by parade continues with Summit Midstream, Sinclair deals; new Calpine bonds busy
|
| 7/8/2014 | BKCVDDEMIGPV | Market Commentary: Calpine, Walter, Magnetation drive by in $3.2 billion day; Radiation Therapy slides more
|
